133 related articles for article (PubMed ID: 16616073)
1. Prolymphocytic leukemias.
Krishnan B; Matutes E; Dearden C
Semin Oncol; 2006 Apr; 33(2):257-63. PubMed ID: 16616073
[TBL] [Abstract][Full Text] [Related]
2. How I treat prolymphocytic leukemia.
Dearden C
Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
[TBL] [Abstract][Full Text] [Related]
3. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper.
Dungarwalla M; Matutes E; Dearden CE
Eur J Haematol; 2008 Jun; 80(6):469-76. PubMed ID: 18331594
[TBL] [Abstract][Full Text] [Related]
4. Current treatment options in prolymphocytic leukemia.
Robak T; Robak P
Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
[TBL] [Abstract][Full Text] [Related]
5. B- and T-cell prolymphocytic leukemia: antibody approaches.
Dearden C
Hematology Am Soc Hematol Educ Program; 2012; 2012():645-51. PubMed ID: 23233647
[TBL] [Abstract][Full Text] [Related]
6. T-cell prolymphocytic leukemia.
Khot A; Dearden C
Expert Rev Anticancer Ther; 2009 Mar; 9(3):365-71. PubMed ID: 19275513
[TBL] [Abstract][Full Text] [Related]
7. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
8. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.
Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W
Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities.
Yokohama A; Karasawa M; Takada S; Matsushima T; Murakami H; Miyao S; Sato S; Naruse T
J Med; 2000; 31(3-4):183-94. PubMed ID: 11280450
[TBL] [Abstract][Full Text] [Related]
10. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
11. Mature T-cell leukemias.
Ravandi F; Kantarjian H; Jones D; Dearden C; Keating M; O'Brien S
Cancer; 2005 Nov; 104(9):1808-18. PubMed ID: 16136598
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody.
Mourad YA; Taher A; Chehal A; Shamseddine A
Ann Hematol; 2004 May; 83(5):319-21. PubMed ID: 15060751
[TBL] [Abstract][Full Text] [Related]
13. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. [Oncogenesis of T-cell prolymphocytic leukemia].
Stern MH
Pathol Biol (Paris); 1996 Oct; 44(8):689-93. PubMed ID: 8977926
[TBL] [Abstract][Full Text] [Related]
16. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
17. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958
[TBL] [Abstract][Full Text] [Related]
18. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
19. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Cao TM; Coutre SE
Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab].
Fløisand Y; Brinch L; Gedde-Dahl T; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2004 Mar; 124(6):768-70. PubMed ID: 15039804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
